Search
SpyGlass Pharma Ord shs (Proposed)
SGPAdd to Watchlist
27.650USD
-0.510-1.81%
Close 09-23 16:00（ET）
924.34MMarket Cap
LossP/E TTM
SGP Analyst Recommendation Trends
In the current month, SGP has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SGP average Analyst price target in the last month is 44.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
4
4
4
4
4
4
0
0
2
2
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
5
5
5
5
0
0
Financial Forecasting
Based on analysts' estimates, SGP EPS is projected to reach -0.623 in FY2026Q3, following reported EPS of -0.594 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
--
-0.50
-0.51
-0.62
-0.65
Actual
-1.25
-0.69
-0.59
--
--
Surprise
--
-37.80%
-15.48%
--
--
FAQs
How have SpyGlass Pharma Ord shs (Proposed)SGP's recent earnings per share performed?
The market expectation was USD -0.59, while SpyGlass Pharma Ord shs (Proposed)SGP's earnings per share (EPS) for the previous quarter was USD -0.69. EPS for the next quarter is expected at USD -0.65.
What is the analyst rating for SpyGlass Pharma Ord shs (Proposed)?
Based on the ratings of SpyGlass Pharma Ord shs (Proposed)'s stock from 6 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.